Galactosamine prevents ethinylestradiol-induced cholestasis

Drug Metabolism and Disposition

Volumn 34, Issue 6, 2006, Pages 993-997

  Crocenzi, Fernando A ^a   Pellegrino, Jośe M ^a   Catania, Viviana A ^a   Luquita, Marcelo G ^a   Roma, Marcelo G ^a   Mottino, Aldo D ^a   Śanchez Pozzi, Enrique J ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILE SALT; BIOLOGICAL MARKER; DRUG METABOLITE; ETHINYLESTRADIOL; ETHINYLESTRADIOL 17 BETA GLUCURONIDE; GALACTOSAMINE; GLUCURONIDE; TAUROURSODEOXYCHOLIC ACID; TRACER; TRITIUM; UNCLASSIFIED DRUG; URIDINE; URIDINE DIPHOSPHATE GLUCURONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BILE FLOW; BILE SECRETION; CHOLESTASIS; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; GLUCURONIDATION; LIVER CELL; LIVER INJURY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; BILE; CHOLESTASIS; ETHINYL ESTRADIOL; GALACTOSAMINE; LIVER; MALE; RATS; RATS, WISTAR; TAUROCHENODEOXYCHOLIC ACID; URIDINE; URIDINE DIPHOSPHATE GLUCURONIC ACID;

ANIMALIA;

EID: 33646785035     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.009308     Document Type: Article

References (31)

1. Adlercreutz H, Tikkanen MJ, Wichmann K, Svanborg A, and Anberg A (1974) Recurrent jaundice in pregnancy. IV. Quantitative determination of urinary and biliary estrogens, including studies in pruritus gravidarum. J Clin Endocrinol Metab 38:51-57.
2. Alary J, Cravedi JP, Baradat M, and Carrera G (1992) Mechanism of cadmium-decreased glucuronidation in the rat. Biochem Pharmacol 44:2139-2147.
3. Alvaro D, Gigliozzi A, Piat C, Carli L, Fraioli F, Romeo R, Francia C, Attili AF, and Capocaccia L (1997) Inhibition of biliary bicarbonate secretion in ethinylestradiol-induced cholestasis is not associated with impaired activity of the Cl-/HCO-3 exchanger in the rat. J Hepatol 26:146-157.
4. Ballatori N and Truong AT (1992) Glutathione as a primary osmotic driving force in hepatic bile formation. Am J Physiol 263:G617-G624.
5. Bouchard G, Yousef IM, and Tuchweber B (1993) Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes. Liver 13:193-202.
6. Bouchard G, Yousef IM, and Tuchweber B (1994) Decreased biliary glutathione content is responsible for the decline in bile salt-independent flow induced by ethinylestradiol in rats. Toxicol Lett 74:221-233.
7. Crocenzi FA, Mottino AD, Cao J, Veggi LM, Sanchez Pozzi EJ, Vore M, Coleman R, and Roma MG (2003) Estradiol-17-βD-glucuronide induces endocytic internalization of Bsep in rats. Am J Physiol 285:G449-G459.
8. Crocenzi FA, Sánchez Pozzi EJ, Pellegrino JM, Favre CO, Rodríguez Garay EA, Mottino AD, Coleman R, and Roma MG (2001) Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets. Hepatology 34:329-339.
9. Davis RA, Elliott TS, Lattier GR, Showalter RB, and Kern F Jr (1986) Regulation of bile acid synthesis via direct effects on the microsomal membrane. Biochemistry 25:1632-1636.
10. Decker K and Keppler D (1972) Galactosamine induced liver injury. Prog Liver Dis 4:183-199.
11. Erlinger S (1994) Bile flow, in The Liver: Biology and Pathobiology (Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, and Shafritz DA eds) pp 769-786, Raven Press, New York.
12. Gregus Z, Madhu C, Goon D, and Klaassen CD (1988) Effect of galactosamine-induced hepatic UDP-glucuronic acid depletion on acetaminophen elimination in rats. Dispositional differences between hepatically and extrahepatically formed glucuronides of acetaminophen and other chemicals. Drug Metab Dispos 16:527-533.
13. Gujral JS, Farhood A, and Jaeschke H (2003) Oncotic necrosis and caspase-dependent apoptosis during galactosamine-induced liver injury in rats. Toxicol Appl Pharmacol 190:37-46.
14. Gumucio JJ and Valdivieso VD (1971) Studies on the mechanism of the ethynylestradiol impairment of bile flow and bile salt excretion in the rat. Gastroenterology 61:339-344.
15. Hardison WG, Hatoff DE, Miyai K, and Weiner RG (1981) Nature of bile acid maximum secretory rate in the rat. Am J Physiol 241:G337-G343.
16. Hardison WG and Wood CA (1978) Importance of bicarbonate in bile salt independent fraction of bile flow. Am J Physiol 235:E158-E164.
17. Jacquemin E, Dumont M, Mallet A, and Erlinger S (1993) Ursodeoxycholic acid improves ethinyl estradiol-induced cholestasis in the rat. Eur J Clin Investig 23:794-802.
18. Keppler DO, Pausch J, and Decker K (1974) Selective uridine triphosphate deficiency induced by D-galactosamine in liver and reversed by pyrimidine nucleotide precursors. Effect on ribonucleic acid synthesis. J Biol Chem 249:211-216.
19. Kern F Jr, Eriksson H, Curstedt T, and Sjövall J (1977) Effect of ethinylestradiol on biliary excretion of bile acids, phosphatidylcolines and cholesterol in the bile fistula rat. J Lipid Res 18:623-634.
20. Koopen NR, Post SM, Wolters H, Havinga R, Stellaard F, Boverhof R, Kuipers F, and Princen HM (1999) Differential effects of 17α- ethinylestradiol on the neutral and acidic pathways of bile salt synthesis in the rat. J Lipid Res 40:100-108.
21. Kubitz R, Wettstein M, Warskulat U, and Häussinger D (1999) Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology 116:401-410.
22. Lee JM, Trauner M, Soroka CJ, Stieger B, Meier PJ, and Boyer JL (2000) Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 118:163-172.
23. Markov AK, Farias LA, Bennett WS, Subramony C, and Mihas AA (1991) Prevention of galactosamine-induced hepatotoxicity in rats with fructose-1,6-diphosphate. Pharmacology 43:310-317.
24. Meyers M, Slikker W, Pascoe G, and Vore M (1980) Characterization of cholestasis induced by estradiol-17 beta-D-glucuronide in the rat. J Pharmacol Exp Ther 214:87-93.
25. Paulusma CC, Kothe MJ, Bakker CT, Bosma PJ, van Bokhoven I, van Marle J, Bolder U, Tytgat GN, and Oude Elferink RP (2000) Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology 31:684-693.
26. Sanchez Pozzi EJ, Crocenzi FA, Pellegrino JM, Catania VA, Luquita MG, Roma MG, Rodriguez Garay EA, and Mottino AD (2003) Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis. J Pharmacol Exp Ther 306:279-286.
27. Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, and Meier PJ (2000) Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 118:422-430.
28. Talalay P (1960) Enzymatic analysis of steroid hormones. Methods Biochem Anal 8:119-143.
29. Tietz PS, Thistle JL, Miller LJ, and LaRusso NF (1984) Development and validation of a method for measuring the glycine and taurine conjugates of bile acids in bile by high-performance liquid chromatography. J Chromatogr 336:249-257.
30. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502-522.
31. Vore M (1987) Estrogen cholestasis. Membranes, metabolites, or receptors? Gastroenterology 93:643-649.